The treatment could potentially help patients reduce the use of glucocorticoids and immunosuppressants, the authors of the study said. The safety and efficacy of efgartigimod for the treatment of ...

Coramitug is well tolerated and leads to a statistically significant reduction in N-terminal pro-brain type natriuretic peptide (NT-proBNP)—a marker of disease progression in transthyretin-mediated ...

Important gains were observed in key areas, including basic theory, transfusion compatibility testing, and clinical transfusion application. A structured 6-month fellowship program in transfusion ...

A pattern recognition approach takes into account factors like disease progression rate, whether the disease symptoms are symmetrical or asymmetrical, whether they are predominantly distal or proximal ...

Rituximab showed a potential benefit on the long-term disease trajectory for MG, keeping disease activity and treatment burden low. The initial placebo-controlled portion of the trial showed the ...

The ODDS score showed strong predictive accuracy for 1-year transplant-free survival across varying levels of disease severity and oxygen needs. Researchers have devised a novel composite score that ...

The recurrence analysis found that the presence or absence of the IL36RN gene was not associated with recurrence. The use of biologics, particularly interleukin-36 (IL-36) inhibition, has resulted in ...

The revisions include the addition of a boxed warning that describes the risk of serious hepatic injury and acute liver failure as well as possible fatal outcomes and the limitation of the use of the ...